MRI-based machine learning tool for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a computer model that learns from MRI scans to predict prostate cancer. If you have had a prostate MRI showing suspicious areas and are scheduled for a biopsy, joining may help improve how cancer is detected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have given permission to participate (informed consent)
- You have one or more suspicious spots on a prostate MRI (PI-RADS score 1 or higher)
- You are scheduled for a prostate biopsy using MRI-ultrasound fusion at the study hospital in Bologna, Italy
- You have not had prior prostate surgery or hormone therapy
- Your MRI images are clear and high quality (no major artifacts from hip implants or probe movement)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
This trial is testing whether a single MRI scan can replace multiple tests to stage prostate cancer. It is for people with more aggressive or advanced prostate cancer who are planning active treatment like surgery or radiation.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
This study uses MRI scans and artificial intelligence to predict the risk of clinically significant prostate cancer. It may help find a way to detect aggressive cancers without needing a biopsy.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.